Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05946993 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Linking In With Advice and Supports for Men Impacted by Metastatic Cancer

Study acronym: LIAM Mc
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary endpoints: details revised at 2 of 4 entries Show 6 more changesShow less
    • Primary completion date changed from estimate of Jun 2026 to Aug 30, 2025
    • Study completion pushed from Jun 2026 to Feb 2028
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 15 of 16 entries
    • Study description expanded, about 7 words
    • Publications: details revised at 1 of 1 entry
  2. Minor Primary completion pushed from Mar 2026 to Jun 2026
    • Study completion pushed from Apr 2026 to Jun 2026
    v6
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date: Nov 2025 to Mar 2026
    • Site details revised
    v5
  4. Notable Primary completion date: Apr 2025 to Nov 2025
    • Study completion date: Apr 2025 to Apr 2026
    • Site details revised
    • Publications: details revised at 1 of 1 entry
    v4
  5. Minor Site contact updatedv3
  6. Notable Primary endpoints revised (4)v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To evaluate the feasibility of introducing a men's cancer survivorship programme into routine follow up care in patients with advanced genitourinary malignancies.
Trial Details
NCT Number NCT05946993
Lead Sponsor University College Cork
Collaborators: Irish Cancer Society, Cancer Research@UCC
Conditions
(from sponsor)
Survivorship, Prostate Cancer, Kidney Cancer, Urothelial Tract/Bladder Cancer, Nos, Testicular Cancer, Penile Cancer
Related terms Kidney Neoplasms, Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Testicular Neoplasms, Urologic Neoplasms
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov